#Inform diagnostics license
Quisitive will license the mobile application to Inform Diagnostics and use the technology to improve patient care across the healthcare ecosystem. “Through their expertise and long-standing commitment to Microsoft technologies, Quisitive is a valuable resource for companies like Inform Diagnostics to help activate capabilities that impact our everyday lives.” Health & Life Sciences at Microsoft Corp. “ It's incredible to see the innovative solutions that Quisitive and other key partners are applying to address new challenges,” said Patty Obermaier, Vice President, U.S. This new innovative solution underscores Inform Diagnostics’ commitment to delivering the right diagnosis the first time, with accuracy, efficiency and speed, while maintaining the highest quality standards. Inform Diagnostics is dedicated to providing clinicians and their patients with advanced subspecialty expertise translating to better patient care through precise diagnoses and timely treatment. We’re excited to continue our relationship with Inform Diagnostics on an important application that directly impacts the speed of delivering anatomic pathology testing results to enhance patient care.” “Now with its modern cloud infrastructure, Inform Diagnostics can expedite development of this new solution and thankfully not be inhibited by legacy systems. “Helping Inform Diagnostics transform into a cloud-first company has enabled quick innovation,” said Mike Reinhart, CEO of Quisitive. This purpose-built solution supports Inform Diagnostics’ commitment to help clinicians capture value and sustainability, with an efficient, innovative solution that saves time and resources. Now in development, the mobile application will provide clinicians with end-to-end, real-time tracking of their patients’ biopsies with 24/7 access to information. The work with Quisitive, Microsoft and other providers facilitated easier integration and interoperability of lab and technology changes into our business and technology platforms, with the goal of improving the clinicians’ experience with ease and speed.” “Through this transformative work, Inform Diagnostics addressed our accrued ‘technical debt,’” said Nancy Gay, President and COO at Inform Diagnostics, “By redesigning and rebuilding our data, process and technology substructure to align with our new future-state architecture, we could better support our growth strategy. The new IT infrastructure replacing legacy systems will be fully deployed across Inform Diagnostics’ labs by year end, including the Phoenix lab providing COVID-19 molecular testing. This transformation has enabled Inform Diagnostics to innovate and scale to provide unparalleled quality, service and solutions to clinicians and their patients. This expanded relationship to build a transformative solution for better patient care builds on Quisitive’s and Inform Diagnostics’ accelerated project over the past 18 months to fully modernize Inform Diagnostics’ IT infrastructure. This purpose-built solution will provide clinicians with real-time information at their point of need. This new collaboration will result in a mobile application powered by Microsoft Azure, Azure Artificial Intelligence (AI) and Microsoft Teams technologies. commercial subspecialty anatomic pathology provider, today announced an agreement to expand their relationship to develop a real-time, biopsy tracking solution. TORONTO and IRVING, Texas – TheNewswire - JQuisitive Technology Solutions (TSXV:QUIS) (OTC:QUISF) and Inform Diagnostics, a leading U.S.
0 kommentar(er)
